Cargando…
Endothelial Cell Amplification of Regulatory T Cells Is Differentially Modified by Immunosuppressors and Intravenous Immunoglobulin
Immunosuppressive treatment is a prerequisite for both organ transplantation and tolerance of the allograft. However, long-term immunosuppression has been associated with a higher incidence of malignancies and infections. Immunosuppressors mainly target circulating immune cells and little is known o...
Autores principales: | Lion, Julien, Burbach, Maren, Cross, Amy, Poussin, Karine, Taflin, Cécile, Kaveri, Srini, Haziot, Alain, Glotz, Denis, Mooney, Nuala |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735077/ https://www.ncbi.nlm.nih.gov/pubmed/29312302 http://dx.doi.org/10.3389/fimmu.2017.01761 |
Ejemplares similares
-
Inflammation Determines the Capacity of Allogenic Endothelial Cells to Regulate Human Treg Expansion
por: Cross, Amy Rachael, et al.
Publicado: (2021) -
Thymodepressin—Unforeseen Immunosuppressor
por: Deigin, Vladislav I., et al.
Publicado: (2021) -
Intravenous immunoglobulin immunotherapy for coronavirus disease‐19 (COVID‐19)
por: Galeotti, Caroline, et al.
Publicado: (2020) -
Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era?
por: Bayry, Jagadeesh, et al.
Publicado: (2004) -
The Role of the Endothelium during Antibody-Mediated Rejection: From Victim to Accomplice
por: Cross, Amy Rachael, et al.
Publicado: (2018)